1. The smoking cessation in pregnancy incentives trial (CPIT): study protocol for a phase III randomised controlled trial
- Author
-
Lesley Sinclair, Margaret McFadden, Helen Tilbrook, Alex Mitchell, Ada Keding, Judith Watson, Linda Bauld, Frank Kee, David Torgerson, Catherine Hewitt, Jennifer McKell, Pat Hoddinott, Fiona M. Harris, Isabelle Uny, Kathleen Boyd, Nicola McMeekin, Michael Ussher, David M. Tappin, and for the CPIT III local research teams
- Subjects
Intervention ,Randomised controlled trial ,Maternal and child health ,Outcomes ,Pregnancy ,Prevention ,Medicine (General) ,R5-920 - Abstract
Abstract Background Eighty per cent of UK women have at least one baby, making pregnancy an opportunity to help women stop smoking before their health is irreparably compromised. Smoking cessation during pregnancy helps protect infants from miscarriage, still birth, low birth weight, asthma, attention deficit disorder and adult cardiovascular disease. UK national guidelines highlight lack of evidence for effectiveness of financial incentives to help pregnant smokers quit. This includes a research recommendation: within a UK context, are incentives an acceptable, effective and cost-effective way to help pregnant women who smoke to quit? Methods The Cessation in Pregnancy Incentives Trial (CPIT) III is a pragmatic, 42-month, multi-centre, parallel-group, individually randomised controlled superiority trial of the effect on smoking status of adding to usual Stop Smoking Services (SSS) support, the offer of up to £400 of financial voucher incentives, compared with usual support alone, to quit smoking during pregnancy. Participants (n = 940) are pregnant smokers (age > 16 years,
- Published
- 2020
- Full Text
- View/download PDF